Sol-Gel Technologies (SLGL) Shareholder's Equity (2016 - 2025)

Sol-Gel Technologies (SLGL) Shareholder's Equity (2016 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 22.81 Mn
Dec 31, 2024 28.85 Mn
Dec 31, 2023 38.64 Mn
Dec 31, 2022 42.21 Mn
Dec 31, 2021 55.59 Mn
Dec 31, 2020 50.85 Mn
Dec 31, 2019 52.47 Mn
Dec 31, 2018 63.91 Mn
Dec 31, 2017 -52.70 Mn
Dec 31, 2016 -31.34 Mn